About My Treatment (GB)
Close Mobile Navigation

References:

  1. KEYTRUDA Patient Information Leaflet.
  2. Understanding MSI-H/dMMR FA.
  3. KEYTRUDA Summary of Product Characteristics.
  4. AVASTIN® (Bevacizumab) Patient Information Leaflet.
  5. INLYTA® (axitinib) Patient Information Leaflet.
  6. KISPLYX® (lenvatinib) Patient Information Leaflet.
  7. LENVIMA® (lenvatinib) Patient Information Leaflet.

Supporting documentation

KEYTRUDA® (pembrolizumab)

Summary of Product Characteristics | Patient Information Leaflet

GB-PDO-02959 | Date of Preparation: January 2024